
Saint Luke’s Cancer Institute and Saint Luke’s Marion Bloch Neuroscience Institute seek a Medical Director of Neuro-Oncology to lead and expand the neuro-oncology clinical program and clinical research portfolio. The director will provide clinical leadership, oversee existing brain tumor clinical trials, and develop new investigator-initiated studies and industry collaborations to broaden therapeutic options for patients. The director will collaborate with multidisciplinary neuroscience teams, including two designated oncologic neurosurgeons, dedicated neuro–radiology, neuro-pathology and a neuro-oncologist joining in July 2026. This is an academic clinical appointment commensurate with experience.
Vision for Neuro-Oncology at Saint Luke’s:
Saint Luke’s is committed to developing a premier neuro-oncology program that delivers exceptional patient-centered care while advancing the science and practice of neuro-oncology. The goal is to become the leading neuro-oncology program in the region, with a clear trajectory toward national recognition for clinical excellence, innovation, and leadership in neuro-oncology clinical research.
A central pillar of the neuro-oncology strategy is the expansion and diversification of the clinical trials portfolio. The Institute seeks to become a regional hub for brain tumor clinical trials, ensuring that patients across the region have access to advanced therapies locally.
With strong leadership, the neuro-oncology program will develop a trial-focused culture in which clinical research is integrated into routine care and trial availability becomes a defining feature of the patient experience.
The Institute maintains a robust academic mission, fostering mentorship, faculty development, and training for future leaders in neuro-oncology. With established neurosurgical oncology expertise and planned expansion of neuro-oncology faculty, the program is positioned for thoughtful growth while maintaining excellence.
Ultimately, Saint Luke’s Cancer Institute in partnership with the Marion Bloch Neuroscience Institute aims to be recognized nationally as a center known for:
High-quality, compassionate neuro-oncology care
Strong clinical trial enrollment and innovation
Multidisciplinary excellence
Leadership in programmatic growth and outcomes
The Director of Neuro-Oncology will play a pivotal role in shaping and executing this vision, serving as a clinical leader, program builder, and advocate for innovation on behalf of patients and the institution.
Key Responsibilities:
Provide clinical care for adult brain tumor patients in inpatient and outpatient settings; maintain high standards of patient-centered care and multidisciplinary coordination.
Provide strategic leadership for neuro-oncology programmatic development, quality improvement, strategic planning, and cross-department collaboration
Assume primary oversight of the active neuro-oncology clinical trials: ensure regulatory compliance, participant safety, data integrity, and timely accrual.
Expand the clinical trial portfolio by pursuing investigator-initiated trials, fostering relationships with industry sponsors, and collaborating with institutional research offices and cancer research networks. Dedicated research coordinators and grant-writing support are available.
Mentor and supervise neuro-oncology faculty, advanced practice providers, and research staff, and support education and training activities.
Participate in weekly tumor board, multidisciplinary clinics, and community/outreach efforts to raise the program’s profile and referral base.
Required Qualifications:
MD, DO, or equivalent degree (or MD/PhD) with board certification (or eligibility) in Neurology, Medical Oncology, or related specialty and fellowship training in Neuro-Oncology.
Active medical license in Missouri (or eligibility to obtain).
Several years (typical: 3+ years) of post-fellowship clinical experience in neuro-oncology with demonstrated clinical trial involvement and experience managing or serving as PI on clinical studies. We are seeking a candidate with demonstrable experience initiating, or leading clinical trials and with a track record of patient accrual and site/study leadership.
Strong leadership, interpersonal, and communication skills with a collaborative approach to multidisciplinary care.
Preferred Qualifications
Experience growing or directing an academic neuro-oncology program or leading a clinical trials portfolio.
Prior experience with investigator-initiated studies, cooperative group trials (e.g., NCI/Alliance/NCTN), and industry-sponsored protocols.
Record of peer-reviewed publications and participation in academic teaching/mentorship.
Position Highlights/Why Saint Luke’s
Saint Luke’s Cancer Institute is known throughout the region as a destination for high quality, personalized cancer care with multidisciplinary support from nationally recognized physician leaders.
The Marion Bloch Neuroscience Institute is the region’s dedicated neuroscience center with strong multidisciplinary resources and active clinical research infrastructure.
The Institute features two designated neurosurgical oncologists/skull base surgeons and will welcome a junior neuro-oncologist in July 2026, providing immediate opportunities for collaboration and development of robust multidisciplinary clinics.
Active clinical trials are currently underway. The incoming director is expected to accelerate patient accrual and expand available offerings.
Academic Appointment & Compensation
Competitive salary and benefits commensurate with experience. Academic appointment and rank at our affiliated medical school (UMKC) will be commensurate with the candidate’s credentials and scholarly record.
Applicable Experience:
Licensure managed by MSO - N/A (Information only, Not certificate)Doctorate DegreeFull TimeDay (United States of America)
The best place to get care. The best place to give care Saint Luke’s 12,000 employees strive toward that vision every day. Our employees are proud to work for the only faith-based, nonprofit, locally owned health system in Kansas City. Joining Saint Luke’s means joining a team of exceptional professionals who strive for excellence in patient care. Do the best work of your career within a highly diverse and inclusive workspace where all voices matter.
J oin the Kansas City region's premiere provider of health services. Equal Opportunity Employer.

About Saint Luke’s
Saint Luke’s serves the West Region of BJC Health System as a faith-based, nonprofit, aligned health system committed to providing the highest levels of excellence in compassionate health care and health-related services. Saint Luke’s cares for patients in 65 specialty services across 67 counties in Missouri and Kansas. Saint Luke’s Hospital has been recognized by U.S. News & World Report as one of the elite hospitals in the nation. For more than 140 years, Saint Luke’s has been dedicated to enhancing the physical, mental, and spiritual health of the diverse communities we serve.
Saint Luke’s offers:
- The region’s longest continuously operating adult heart transplant program and one of the nation’s leading cardiovascular programs at Saint Luke's Mid America Heart Institute
- Treatment for complex brain and spinal cord diseases and one of the nation’s leading stroke reversal programs at the nationally ranked Saint Luke’s Marion Bloch Neuroscience Institute
- The region’s only treatment center dedicated exclusively to treating metastatic breast cancer—the Koontz Center for Advanced Breast Cancer at Saint Luke’s Cancer Institute
- Saint Luke’s Convenient and Urgent Care clinics for treatment of minor illnesses and injuries
- Liver and kidney transplantation programs
- A comprehensive maternal-fetal diagnostic and treatment center
- Three Neonatal Intensive Care Units, including a Level IIIb NICU at Saint Luke’s Hospital of Kansas City
- Saint Luke’s Rehabilitation Institute, the only comprehensive inpatient rehabilitation hospital of its kind in the region
- A nationally recognized children's behavioral health center, Saint Luke’s Hospital Crittenton Children’s Center